Evolution of non-cytotoxic uterine natural killer cells
- PMID: 18405313
- PMCID: PMC3042548
- DOI: 10.1111/j.1600-0897.2008.00595.x
Evolution of non-cytotoxic uterine natural killer cells
Abstract
The immune tolerance and de novo vascularization are two highly intriguing processes at the maternal-fetal interface that appear to be central to normal pregnancy outcome. Immune tolerance occurs despite the local presence of an active maternal immune system including macrophages, dendritic cells and specialized CD56(bright)CD16(-) uterine natural killer (uNK) cells (65-70%). Recent observations indicate that the phenotypic and functional repertoire of uNK cells is distinct from peripheral blood NK and endometrial NK cells, challenging the understanding of their temporal occurrence and function. Origin and specialized programming of uNK cells continue to be debated. uNK cells, replete with an armamentarium to kill the foreign, tolerate the conceptus and facilitate pregnancy. Why do these uNK cells remain non-cytotoxic? Are these NK cells 'multitasking' in nature harboring beneficial and detrimental roles in pregnancy? Are there distinct subpopulations of NK cells that may populate the decidua? We propose that the endometrium/decidua functions as an 'inducible tertiary lymphoid tissue' that supports the recruitment and expansion of CD56(bright)CD16(-) NK cells and induces transcriptional up-regulation of angiogenic machinery in response to exposure to local hormonal factors, cytokine milieu and perhaps hypoxia. The angiogenic features of uNK cells could further result in a 'multitasking' phenotype that still remains to be characterized. This article discusses the factors and pathways that bridge the angiogenic and non-cytotoxic response machineries at the maternal-fetal interface.
Figures
angiogenic factors;
cytolysis machinery Abbreviations: VEGF C, vascular endothelial growth factor C; PlGF, placenta growth factor; IP 10, interferon gamma inducible proteinSimilar articles
-
Natural killer cell-triggered vascular transformation: maternal care before birth?Cell Mol Immunol. 2011 Jan;8(1):1-11. doi: 10.1038/cmi.2010.38. Epub 2010 Aug 16. Cell Mol Immunol. 2011. PMID: 20711229 Free PMC article. Review.
-
NK cell tolerance and the maternal-fetal interface.Am J Reprod Immunol. 2008 May;59(5):371-87. doi: 10.1111/j.1600-0897.2008.00593.x. Am J Reprod Immunol. 2008. PMID: 18405308 Review.
-
Vascular endothelial growth factor C facilitates immune tolerance and endovascular activity of human uterine NK cells at the maternal-fetal interface.J Immunol. 2009 Apr 1;182(7):4085-92. doi: 10.4049/jimmunol.0803769. J Immunol. 2009. PMID: 19299706 Free PMC article.
-
Uterine natural killer cells pace early development of mouse decidua basalis.Mol Hum Reprod. 2014 Jan;20(1):66-76. doi: 10.1093/molehr/gat060. Epub 2013 Sep 1. Mol Hum Reprod. 2014. PMID: 24000237
-
Maternal obesity alters uterine NK activity through a functional KIR2DL1/S1 imbalance.Immunol Cell Biol. 2018 Sep;96(8):805-819. doi: 10.1111/imcb.12041. Epub 2018 Apr 16. Immunol Cell Biol. 2018. PMID: 29569748
Cited by
-
Placental galectins regulate innate and adaptive immune responses in pregnancy.Front Immunol. 2022 Dec 28;13:1088024. doi: 10.3389/fimmu.2022.1088024. eCollection 2022. Front Immunol. 2022. PMID: 36643922 Free PMC article.
-
TLR9 activation coupled to IL-10 deficiency induces adverse pregnancy outcomes.J Immunol. 2009 Jul 15;183(2):1144-54. doi: 10.4049/jimmunol.0900788. Epub 2009 Jun 26. J Immunol. 2009. PMID: 19561095 Free PMC article.
-
Maternal-fetal cross talk through cell-free fetal DNA, telomere shortening, microchimerism, and inflammation.Am J Reprod Immunol. 2018 May;79(5):e12851. doi: 10.1111/aji.12851. Epub 2018 Mar 25. Am J Reprod Immunol. 2018. PMID: 29577468 Free PMC article. Review.
-
Differential effects of the CpG-Toll-like receptor 9 axis on pregnancy outcome in nonobese diabetic mice and wild-type controls.Fertil Steril. 2013 May;99(6):1759-67. doi: 10.1016/j.fertnstert.2013.01.121. Epub 2013 Feb 13. Fertil Steril. 2013. PMID: 23414919 Free PMC article.
-
Molecular evidence for natural killer-like cells in equine endometrial cups.Placenta. 2012 May;33(5):379-86. doi: 10.1016/j.placenta.2012.01.018. Epub 2012 Feb 21. Placenta. 2012. PMID: 22357194 Free PMC article.
References
-
- Drayton DL, Liao S, Mounzer RH, Ruddle NH. Lymphoid organ development: from ontogeny to neogenesis. Nat Immunol. 2006;7:344–353. - PubMed
-
- Sargent IL, Borzychowski AM, Redman CW. NK cells and human pregnancy--an inflammatory view. Trends Immunol. 2006;27:399–404. - PubMed
-
- Moffett A, Loke C. Immunology of placentation in eutherian mammals. Nat Rev Immunol. 2006;6:584–594. - PubMed
-
- Bulmer JN, Morrison L, Longfellow M, Ritson A, Pace D. Granulated lymphocytes in human endometrium: histochemical and immunohistochemical studies. Hum Reprod. 1991;6:791–798. - PubMed
-
- Colucci F, Caligiuri MA, Di Santo JP. What does it take to make a natural killer? Nat Rev Immunol. 2003;3:413–425. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Research Materials
